Prevalence Rate of Adverse Drug Reactions from Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study

<b>Background/Objectives</b>: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are widely used in type 2 diabetes mellitus for glycemic control and cardiovascular–renal protection, but adverse effects such as acute kidney injury (AKI), urinary tract infection (UTI), euglycemic diabetic ketoacidosis...

Descrición completa

Detalles Bibliográficos

Principais autores:	Pichitra Srimaya, Tossapol Warong, Sudarat Kingdang, Titawadee Pradubkham, Wiraphol Phimarn
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2025-12-01
Series:	Pharmacoepidemiology
Assuntos:	sodium-glucose cotransporter-2 inhibitors acute kidney injury urinary tract infection diabetic ketoacidosis pancreatitis type 2 diabetes mellitus
Acceso en liña:	https://www.mdpi.com/2813-0618/5/1/2
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!